Biomerica INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
Biomerica, Inc. has filed a Definitive Proxy Statement with the SEC, signaling an upcoming shareholder vote.
NASDAQ
Biomerica, Inc. filed a DEF 14A proxy statement outlining proposals for its 2025 Annual Meeting, including a significant increase in authorized common stock and amendments to its stock incentive plan.
NASDAQ
Biomerica, Inc. is holding its annual meeting on December 13, 2024, seeking stockholder approval for several key proposals, including a reverse stock split, a new stock incentive plan, and amendments to the company's certificate of incorporation.